PMID- 38020065 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231201 IS - 1687-4757 (Print) IS - 1687-4765 (Electronic) VI - 2023 DP - 2023 TI - Peroxisome Proliferator-Activated Receptor gamma Regulates Lipid Metabolism in Sheep Trophoblast Cells through mTOR Pathway-Mediated Autophagy. PG - 6422804 LID - 10.1155/2023/6422804 [doi] LID - 6422804 AB - Peroxisome proliferator-activated receptor gamma (PPARgamma) is a key nuclear receptor transcription factor that is highly expressed in trophoblastic cells during embryonic attachment and is accompanied by rapid cell proliferation and increased lipid accumulation. We previously showed that the autophagy pathway is activated in cells after activation of PPARgamma, accompanied by increased lipid accumulation. In this study, we used PPARgamma agonist rosiglitazone and inhibitor GW9662, as well as autophagy activator rapamycin and inhibitor 3-methyladenine, to unravel the probable mechanism of PPARgamma engaged in lipid metabolism in sheep trophoblast cells (STCs). After 12 h, 24 h, and 48 h of drug treatment, the levels of autophagy-related proteins were detected by Western blot, the triglyceride content and MDA level of cells were detected by colorimetry, and the lipid droplets and lysosomes were localized by immunofluorescence. We found that PPARgamma inhibited the activity of mammalian target of rapamycin (mTOR) pathway in STCs for a certain period of time, promoted the increase of autophagy and lysosome formation, and enhanced the accumulation of lipid droplets and triglycerides. Compared with cells whose PPARgamma function is activated, blocking autophagy before activating PPARgamma will hinder lipid accumulation in STCs. Pretreatment of cells with rapamycin promoted autophagy with results similar to rosiglitazone treatment, while inhibition of autophagy with 3-methyladenine reduced lysosome and lipid accumulation. Based on these observations, we conclude that PPARgamma can induce autophagy by blocking the mTOR pathway, thereby promoting the accumulation of lipid droplets and lysosomal degradation, providing an energy basis for the rapid proliferation of trophoblast cells during embryo implantation. In brief, this study partially revealed the molecular regulatory mechanism of PPARgamma, mTOR pathway, and autophagy on trophoblast cell lipid metabolism, which provides a theoretical basis for further exploring the functional regulatory network of trophoblast cells during the attachment of sheep embryos. CI - Copyright (c) 2023 Kexing Hao et al. FAU - Hao, Kexing AU - Hao K AD - State Key Laboratory of Sheep Genetic Improvement and Healthy Production/Institute of Animal Husbandry and Veterinary, Xinjiang Academy of Agricultural and Reclamation Sciences, Shihezi, China. AD - College of Animal Science and Technology, Shihezi University, Shihezi 832000, China. FAU - Wang, Jing AU - Wang J AD - State Key Laboratory of Sheep Genetic Improvement and Healthy Production/Institute of Animal Husbandry and Veterinary, Xinjiang Academy of Agricultural and Reclamation Sciences, Shihezi, China. AD - College of Animal Science and Technology, Shihezi University, Shihezi 832000, China. FAU - Yu, Hengbin AU - Yu H AD - College of Animal Science and Technology, Shihezi University, Shihezi 832000, China. FAU - Chen, Lei AU - Chen L AD - College of Animal Science and Technology, Shihezi University, Shihezi 832000, China. FAU - Zeng, Weibin AU - Zeng W AD - College of Animal Science and Technology, Shihezi University, Shihezi 832000, China. FAU - Wang, Zhengrong AU - Wang Z AUID- ORCID: 0000-0001-7169-2567 AD - State Key Laboratory of Sheep Genetic Improvement and Healthy Production/Institute of Animal Husbandry and Veterinary, Xinjiang Academy of Agricultural and Reclamation Sciences, Shihezi, China. FAU - Hu, Guangdong AU - Hu G AUID- ORCID: 0000-0002-9710-6500 AD - College of Animal Science and Technology, Shihezi University, Shihezi 832000, China. LA - eng PT - Journal Article DEP - 20231108 PL - United States TA - PPAR Res JT - PPAR research JID - 101269101 PMC - PMC10651342 COIS- The authors have no conflicts of interest to declare. EDAT- 2023/11/29 18:42 MHDA- 2023/11/29 18:43 PMCR- 2023/11/08 CRDT- 2023/11/29 14:38 PHST- 2023/08/04 00:00 [received] PHST- 2023/10/03 00:00 [revised] PHST- 2023/10/14 00:00 [accepted] PHST- 2023/11/29 18:43 [medline] PHST- 2023/11/29 18:42 [pubmed] PHST- 2023/11/29 14:38 [entrez] PHST- 2023/11/08 00:00 [pmc-release] AID - 10.1155/2023/6422804 [doi] PST - epublish SO - PPAR Res. 2023 Nov 8;2023:6422804. doi: 10.1155/2023/6422804. eCollection 2023.